Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Granger

Showing results (961-970 of 1,023) with videos related to

Pageof 103
Sort By:
Circulation|July 6, 2021
Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology CommunityAdam J Nelson, Neha J Pagidipati, Vanita R Aroda, et al.
Circulation|November 16, 2017
Impact of Regionalization of ST-Segment-Elevation Myocardial Infarction Care on Treatment Times and Outcomes for Emergency Medical Services-Transported Patients Presenting to Hospitals With Percutaneous Coronary Intervention: Mission: Lifeline Accelerator-2James G Jollis, Hussein R Al-Khalidi, Mayme L Roettig, et al.
JAMA|November 6, 2007
Implementation of a statewide system for coronary reperfusion for ST-segment elevation myocardial infarctionJames G Jollis, Mayme L Roettig, Akinyele O Aluko, et al.
American Heart Journal|April 11, 2022
Discontinuing vs continuing ACEIs and ARBs in hospitalized patients with COVID-19 according to disease severity: Insights from the BRACE CORONA trialAriane Vieira Scarlatelli Macedo, Pedro Gabriel Melo de Barros E Silva, Thiago Ceccatto de Paula, et al.
JACC. Advances|August 13, 2024
Characteristics and Outcomes of Adults With Congenital Heart Disease in the Cardiac Intensive Care UnitRyan R Keane, Anthony P Carnicelli, Daniel B Loriaux, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 31, 2025
Cost-effectiveness of Apixaban vs Aspirin for the Reduction of Thrombo-Embolism in High-Risk Patients with Device-Detected Atrial Fibrillation: Insights from the ARTESiA trialAndre Lamy, Roopinder K Sandhu, Wesley Tong, et al.
Journal of Thrombosis and Thrombolysis|March 27, 2009
Highlights from the I international symposium of thrombosis and anticoagulation in internal medicine, October 23-25, 2008, Sao Paulo, BrazilRenato D Lopes, Richard C Becker, David Garcia, et al.
The American Journal of Medicine|January 3, 2015
Late Consequences of Acute Coronary Syndromes: Global Registry of Acute Coronary Events (GRACE) Follow-upSami M A Alnasser, Wei Huang, Joel M Gore, et al.
Circulation|November 6, 2022
Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled TrialSean D Pokorney, Glenn M Chertow, Hussein R Al-Khalidi, et al.
The New England Journal of Medicine|May 16, 2019
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined SourceHans-Christoph Diener, Ralph L Sacco, J Donald Easton, et al.
Pageof 103

Showing results (961-970 of 1,023) with videos related to

Sort By:
Pageof 103
Circulation|July 6, 2021
Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology CommunityAdam J Nelson, Neha J Pagidipati, Vanita R Aroda, et al.
Circulation|November 16, 2017
Impact of Regionalization of ST-Segment-Elevation Myocardial Infarction Care on Treatment Times and Outcomes for Emergency Medical Services-Transported Patients Presenting to Hospitals With Percutaneous Coronary Intervention: Mission: Lifeline Accelerator-2James G Jollis, Hussein R Al-Khalidi, Mayme L Roettig, et al.
JAMA|November 6, 2007
Implementation of a statewide system for coronary reperfusion for ST-segment elevation myocardial infarctionJames G Jollis, Mayme L Roettig, Akinyele O Aluko, et al.
American Heart Journal|April 11, 2022
Discontinuing vs continuing ACEIs and ARBs in hospitalized patients with COVID-19 according to disease severity: Insights from the BRACE CORONA trialAriane Vieira Scarlatelli Macedo, Pedro Gabriel Melo de Barros E Silva, Thiago Ceccatto de Paula, et al.
JACC. Advances|August 13, 2024
Characteristics and Outcomes of Adults With Congenital Heart Disease in the Cardiac Intensive Care UnitRyan R Keane, Anthony P Carnicelli, Daniel B Loriaux, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 31, 2025
Cost-effectiveness of Apixaban vs Aspirin for the Reduction of Thrombo-Embolism in High-Risk Patients with Device-Detected Atrial Fibrillation: Insights from the ARTESiA trialAndre Lamy, Roopinder K Sandhu, Wesley Tong, et al.
Journal of Thrombosis and Thrombolysis|March 27, 2009
Highlights from the I international symposium of thrombosis and anticoagulation in internal medicine, October 23-25, 2008, Sao Paulo, BrazilRenato D Lopes, Richard C Becker, David Garcia, et al.
The American Journal of Medicine|January 3, 2015
Late Consequences of Acute Coronary Syndromes: Global Registry of Acute Coronary Events (GRACE) Follow-upSami M A Alnasser, Wei Huang, Joel M Gore, et al.
Circulation|November 6, 2022
Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled TrialSean D Pokorney, Glenn M Chertow, Hussein R Al-Khalidi, et al.
The New England Journal of Medicine|May 16, 2019
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined SourceHans-Christoph Diener, Ralph L Sacco, J Donald Easton, et al.
Pageof 103